Literature DB >> 21199447

Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems.

Jussi Hirvonen1, Jarmo Hietala.   

Abstract

Multiple neurotransmitter circuits are disturbed in schizophrenia, and the dopamine hypothesis of schizophrenia prevails as the hypothesis with most empirical support. On the other hand, schizophrenia is highly heritable with a pattern consistent with both common and rare allelic variants and gene × environment interaction. Advances in the field of neuroimaging have expanded our knowledge of intermediate phenotypes, the neurobiological processes that convey the risk from the genes to the complex phenotype. In this article, we review the recent and continuously accumulating evidence from in vivo imaging studies aiming at characterizing neurochemical intermediate phenotypes of schizophrenia. Dopaminergic alterations in schizophrenia are shared by individuals at genetic risk who do not express the illness, suggesting a "dopamine hypothesis of schizophrenia vulnerability." This hypothesis has the potential to help us better understand the dopaminergic dysfunction in the context of the complex pathophysiological process leading to schizophrenia. In the future, neurotransmitter imaging studies should investigate the gene × environment interaction in schizophrenia, and try to identify neurobiological correlates of heightened sensitivity to environmental stressors (e.g., cannabis, childhood trauma, and other psychosocial stress) in genetically vulnerable individuals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21199447      PMCID: PMC6493880          DOI: 10.1111/j.1755-5949.2010.00223.x

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  114 in total

Review 1.  D(1) receptors in prefrontal cells and circuits.

Authors:  P S Goldman-Rakic; E C Muly; G V Williams
Journal:  Brain Res Brain Res Rev       Date:  2000-03

2.  Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography.

Authors:  A Laakso; H Vilkman; B Alakare; M Haaparanta; J Bergman; O Solin; J Peurasaari; V Räkköläinen; E Syvälahti; J Hietala
Journal:  Am J Psychiatry       Date:  2000-02       Impact factor: 18.112

Review 3.  The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum.

Authors:  D Joel; I Weiner
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

4.  The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia.

Authors:  A Bertolino; A Breier; J H Callicott; C Adler; V S Mattay; M Shapiro; J A Frank; D Pickar; D R Weinberger
Journal:  Neuropsychopharmacology       Date:  2000-02       Impact factor: 7.853

Review 5.  Schizophrenia: genes and environment.

Authors:  M Tsuang
Journal:  Biol Psychiatry       Date:  2000-02-01       Impact factor: 13.382

Review 6.  Increased dopamine transmission in schizophrenia: relationship to illness phases.

Authors:  M Laruelle; A Abi-Dargham; R Gil; L Kegeles; R Innis
Journal:  Biol Psychiatry       Date:  1999-07-01       Impact factor: 13.382

7.  The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia.

Authors:  A Bertolino; M B Knable; R C Saunders; J H Callicott; B Kolachana; V S Mattay; J Bachevalier; J A Frank; M Egan; D R Weinberger
Journal:  Biol Psychiatry       Date:  1999-03-15       Impact factor: 13.382

8.  The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia.

Authors:  T D Cannon; M O Huttunen; J Lonnqvist; A Tuulio-Henriksson; T Pirkola; D Glahn; J Finkelstein; M Hietanen; J Kaprio; M Koskenvuo
Journal:  Am J Hum Genet       Date:  2000-07-03       Impact factor: 11.025

Review 9.  Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.

Authors:  M Laruelle
Journal:  J Cereb Blood Flow Metab       Date:  2000-03       Impact factor: 6.200

10.  Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.

Authors:  L H Lindström; O Gefvert; G Hagberg; T Lundberg; M Bergström; P Hartvig; B Långström
Journal:  Biol Psychiatry       Date:  1999-09-01       Impact factor: 13.382

View more
  11 in total

1.  The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans.

Authors:  Madhav Thambisetty; Kathy A Gallardo; Jeih-San Liow; Lori L Beason-Held; John C Umhau; Abesh K Bhattacharjee; Margaret Der; Peter Herscovitch; Judith L Rapoport; Stanley I Rapoport
Journal:  J Cereb Blood Flow Metab       Date:  2011-12-14       Impact factor: 6.200

Review 2.  MicroRNAs in neuronal communication.

Authors:  Guilherme Shigueto Vilar Higa; Erica de Sousa; Lais Takata Walter; Erika Reime Kinjo; Rodrigo Ribeiro Resende; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2014-01-03       Impact factor: 5.590

Review 3.  Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.

Authors:  Jan-Peter van Wieringen; Jan Booij; Vladimir Shalgunov; Philip Elsinga; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-09       Impact factor: 3.000

4.  Mapping neurotransmitter networks with PET: an example on serotonin and opioid systems.

Authors:  Lauri Tuominen; Lauri Nummenmaa; Liisa Keltikangas-Järvinen; Olli Raitakari; Jarmo Hietala
Journal:  Hum Brain Mapp       Date:  2013-05-14       Impact factor: 5.038

Review 5.  Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networks.

Authors:  Frank S Menniti; Craig W Lindsley; P Jeffrey Conn; Jayvardhan Pandit; Panayiotis Zagouras; Robert A Volkmann
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 6.  Are Essential Trace Elements Effective in Modulation of Mental Disorders? Update and Perspectives.

Authors:  Mehran Shayganfard
Journal:  Biol Trace Elem Res       Date:  2021-04-27       Impact factor: 3.738

7.  Intra- and inter-frequency brain network structure in health and schizophrenia.

Authors:  Felix Siebenhühner; Shennan A Weiss; Richard Coppola; Daniel R Weinberger; Danielle S Bassett
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

8.  Beyond dopamine: glutamate as a target for future antipsychotics.

Authors:  Kyra-Verena Sendt; Giovanni Giaroli; Derek K Tracy
Journal:  ISRN Pharmacol       Date:  2012-07-05

9.  Reduced expression of STOP/MAP6 in mice leads to cognitive deficits.

Authors:  Julien Volle; Jacques Brocard; Mohamed Saoud; Sylvie Gory-Faure; Jérôme Brunelin; Annie Andrieux; Marie-Françoise Suaud-Chagny
Journal:  Schizophr Bull       Date:  2012-09-20       Impact factor: 9.306

Review 10.  Epigenetics, stress, and their potential impact on brain network function: a focus on the schizophrenia diatheses.

Authors:  Vaibhav A Diwadkar; Angela Bustamante; Harinder Rai; Monica Uddin
Journal:  Front Psychiatry       Date:  2014-06-23       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.